Current through Register Vol. 30, No. 50, December 13, 2024
Section R4-23-674 - Limited-service Long-term Care PharmacyA.A limited-service pharmacy permittee shall ensure that the limited-service long-term care pharmacy complies with: 1. The general requirements of R4-23-671;2. The professional practice standards of Article 4 and Article 11; and3. The permits and drug distribution standards of R4-23-606 through R4-23-612, R4-23-670, and this Section.B.If a limited-service long-term care pharmacy permittee contracts with a long-term care facility as a Provider Pharmacy, as defined in R4-23-110, the limited-service long-term care pharmacy permittee shall ensure that the long-term care consultant pharmacist and the pharmacist-in-charge of the limited-service long-term care pharmacy comply with R4-23-701, R4-23-701.01, R4-23-701.02, R4-23-701.03, R4-23-701.04, and this Section. the long-term care consultant pharmacist and the pharmacist-in-charge of the limited-service long-term care pharmacy comply with R4-23-701, R4-23-701.01, R4-23-701.02, R4-23-701.03, R4-23-701.04, and this Section.
C.The limited-service long-term care pharmacy permittee or pharmacist-in-charge shall ensure that prescription medication is delivered to the patient's long-term care facility or locked in the dispensing area of the pharmacy when a pharmacist is not present in the pharmacy.D.The pharmacist-in-charge of a limited-service long-term care pharmacy shall authorize only those individuals listed in R4-23-610(B) to be in the limited-service long-term care pharmacy.E.In consultation with the long-term care facility's medical director and director of nursing, the long-term care consultant pharmacist and pharmacist-in-charge of the long-term care facility's provider pharmacy may develop, if necessary, a medication formulary for the long-term care facility that ensures the safe and efficient procurement, dispensing, distribution, administration, and control of drugs in the long-term care facility.F.The limited-service long-term care pharmacy permittee or pharmacist-in-charge shall ensure that the written policies and procedures required in R4-23-671(E) include the following: 1. Clinical services and drug utilization management for:a. Drug utilization reviews,c. Patient outcome monitoring,e. Education of pharmacy and other health professionals;2. Controlled substances;3. Drug compounding, dispensing, and storage;4. Drug delivery requirements for:c. Temperature and other environmental controls, and5. Drug product procurement;6. Duties and qualifications of professional and support staff;7. Emergency drug supply unit procedures;8. Formulary, including development, review, modification, use, and documentation, if applicable;11. Prescription orders, including:a. Approved abbreviations,b. Stop-order procedures, andc. Leave-of-absence and discharge prescription order procedures;12. Quality management procedures for: a. Adverse drug reactions,c. Expired and beyond-use-date drugs,d. Medication or dispensing errors, ande. Education of professional and support staff;Ariz. Admin. Code § R4-23-674
New Section made by final rulemaking at 9 A.A.R. 1064, effective May 4, 2003 (Supp. 03-1). Amended by final rulemaking at 10 A.A.R. 1192, effective May 1, 2004 (Supp. 04-1). Amended by final rulemaking at 19 A.A.R. 2894, effective November 10, 2013.